4.7 Article

A calpain-6/YAP axis in sarcoma stem cells that drives the outgrowth of tumors and metastases

Journal

CELL DEATH & DISEASE
Volume 13, Issue 9, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41419-022-05244-3

Keywords

-

Categories

Funding

  1. Societe Francaise de lutte Contre les Cancers et les leucemies de l'Enfant et de l'adolescent (SFCE)
  2. Federation Enfants et Sante [R20127HH]
  3. Ligue contre le cancer [R20079HH]
  4. French Society of Orthopaedic Surgery (SOFCOT)

Ask authors/readers for more resources

This study reveals the involvement of calpain-6 in promoting tumor growth and metastasis in sarcoma stem cells. Calpain-6 modulates the expression of Hippo pathway genes and stabilizes YAP, as well as regulates the vesicular trafficking of beta-catenin degradation complexes. The expression of calpain-6 is associated with genes related to the G2M phase of the cell cycle and up-regulated genes controlling mitosis in sarcoma stem cells and tissues. In mouse models, YAP inhibition prevents the formation of primary tumors and metastases, but has no effect on already established tumors and can even accelerate lung metastasis associated with large bone tumors.
Sarcomas include cancer stem cells, but how these cells contribute to local and metastatic relapse is largely unknown. We previously showed the pro-tumor functions of calpain-6 in sarcoma stem cells. Here, we use an osteosarcoma cell model, osteosarcoma tissues and transcriptomic data from human tumors to study gene patterns associated with calpain-6 expression or suppression. Calpain-6 modulates the expression of Hippo pathway genes and stabilizes the hippo effector YAP. It also modulates the vesicular trafficking of beta-catenin degradation complexes. Calpain-6 expression is associated with genes of the G2M phase of the cell cycle, supports G2M-related YAP activities and up-regulated genes controlling mitosis in sarcoma stem cells and tissues. In mouse models of bone sarcoma, most tumor cells expressed calpain-6 during the early steps of tumor out-growth. YAP inhibition prevented the neoformation of primary tumors and metastases but had no effect on already developed tumors. It could even accelerate lung metastasis associated with large bone tumors by affecting tumor-associated inflammation in the host tissues. Our results highlight a specific mechanism involving YAP transcriptional activity in cancer stem cells that is crucial during the early steps of tumor and metastasis outgrowth and that could be targeted to prevent sarcoma relapse.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available